Esparza-DÃaz, J.D.T.; Gamez-Nava, J.I.; Gonzalez-Lopez, L.; Saldaña-Cruz, A.M.; Machado-Sulbaran, A.C.; Beltrán-RamÃrez, A.; Guillén-Medina, M.R.; Flores-Vargas, A.G.; Pérez-Guerrero, E.E.
Elevated Serum Levels of YKL-40, YKL-39, and SI-CLP in Patients with Treatment Failure to DMARDs in Patients with Rheumatoid Arthritis. Biomedicines 2024, 12, 1406.
https://doi.org/10.3390/biomedicines12071406
AMA Style
Esparza-DÃaz JDT, Gamez-Nava JI, Gonzalez-Lopez L, Saldaña-Cruz AM, Machado-Sulbaran AC, Beltrán-RamÃrez A, Guillén-Medina MR, Flores-Vargas AG, Pérez-Guerrero EE.
Elevated Serum Levels of YKL-40, YKL-39, and SI-CLP in Patients with Treatment Failure to DMARDs in Patients with Rheumatoid Arthritis. Biomedicines. 2024; 12(7):1406.
https://doi.org/10.3390/biomedicines12071406
Chicago/Turabian Style
Esparza-DÃaz, José David Tadeo, Jorge Ivan Gamez-Nava, Laura Gonzalez-Lopez, Ana Miriam Saldaña-Cruz, Andrea Carolina Machado-Sulbaran, Alberto Beltrán-RamÃrez, Miryam Rosario Guillén-Medina, Ana Gabriela Flores-Vargas, and Edsaúl Emilio Pérez-Guerrero.
2024. "Elevated Serum Levels of YKL-40, YKL-39, and SI-CLP in Patients with Treatment Failure to DMARDs in Patients with Rheumatoid Arthritis" Biomedicines 12, no. 7: 1406.
https://doi.org/10.3390/biomedicines12071406
APA Style
Esparza-DÃaz, J. D. T., Gamez-Nava, J. I., Gonzalez-Lopez, L., Saldaña-Cruz, A. M., Machado-Sulbaran, A. C., Beltrán-RamÃrez, A., Guillén-Medina, M. R., Flores-Vargas, A. G., & Pérez-Guerrero, E. E.
(2024). Elevated Serum Levels of YKL-40, YKL-39, and SI-CLP in Patients with Treatment Failure to DMARDs in Patients with Rheumatoid Arthritis. Biomedicines, 12(7), 1406.
https://doi.org/10.3390/biomedicines12071406
